Consolidated Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
CURRENT ASSETS
Cash	$ 0	$ 252
Inventory	10,128	10,128
Total Current Assets	10,128	10,380
TOTAL ASSETS	10,128	10,380
CURRENT LIABILITIES
Bank overdraft	894	0
Accounts payable	754,191	609,505
Accounts payable and accrued expenses related party	330,599	222,738
Accrued expenses	175,910	106,982
Note payable	10,000	0
Convertible note payable (net of debt discount)	541,944	497,951
Total Current Liabilities	1,813,538	1,437,176
Long term Liabilities
PPP loan	95,485	201,352
Total longterm liabilities	95,485	201,352
Total Liabilities	1,909,023	1,638,528
Commitments and Contingencies	0	0
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock; $0.0001 par value, 35,000,000 shares authorized, 10,000,000 shares issued and outstanding as of September 30, 2021 and December 31, 2020 respectively	1,000	1,000
Common stock; $0.0001 par value, 465,000,000 shares authorized, 97,276,300 and 84,738,300 issued and outstanding as of September 30, 2021 and December 31, 2020	9,727	8,472
Shares to be issued	11,803	13,803
Additional paid-in capital	2,445,227	2,069,582
Accumulated deficit	(4,366,652)	(3,721,005)
Total Stockholders' Equity (Deficit)	(1,898,895)	(1,628,148)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 10,128	$ 10,380